KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Operating Leases (2019 - 2025)

Guardant Health (GH) has disclosed Operating Leases for 7 consecutive years, with $206.1 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 25.47% to $206.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $206.1 million through Dec 2025, up 25.47% year-over-year, with the annual reading at $206.1 million for FY2025, 25.47% up from the prior year.
  • Operating Leases hit $206.1 million in Q4 2025 for Guardant Health, down from $211.8 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $226.1 million in Q4 2021 to a low of $164.3 million in Q4 2024.
  • Historically, Operating Leases has averaged $206.3 million across 5 years, with a median of $210.9 million in 2022.
  • Biggest five-year swings in Operating Leases: surged 543.48% in 2021 and later fell 22.33% in 2024.
  • Year by year, Operating Leases stood at $226.1 million in 2021, then fell by 7.09% to $210.0 million in 2022, then decreased by 11.51% to $185.8 million in 2023, then fell by 11.6% to $164.3 million in 2024, then grew by 25.47% to $206.1 million in 2025.
  • Business Quant data shows Operating Leases for GH at $206.1 million in Q4 2025, $211.8 million in Q3 2025, and $192.3 million in Q2 2025.